Reply to: Pioneering combination: Nivolumab and isolated limb perfusion in melanoma in-transit metastases treatment.

Holmberg CJ, Zijlker LP, Katsarelias D, Huibers AE, Wouters M, Schrage Y, Reijers SJM, van Thienen JV, Grünhagen DJ, Martner A, Nilsson JA, van Akkooi ACJ, Ny L, van Houdt WJ, Olofsson Bagge R. Eur J Surg Oncol, (Sep 7 2024): 108653, doi:10.1016/j.ejso.2024.108653.